Wall Street Analysts Predict a 447% Upside in AlloVir, Inc. (ALVR): Here's What You Should Know

This article was originally published on Nasdaq

Shares of AlloVir, Inc. (ALVR) have gained 24.6% over the past four weeks to close the last trading session at $5.53, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targe

Responses